Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Leslie Oluwayowa Ojeaburu, M.D.

Concepts (17)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Muscle Neoplasms120211300.170 Why?
Cystectomy120216340.130 Why?
Lymph Node Excision1202112730.120 Why?
Chemotherapy, Adjuvant1202135120.100 Why?
Neoadjuvant Therapy1202128230.080 Why?
Urinary Bladder Neoplasms1202122100.080 Why?
Neoplasm Invasiveness1202135880.030 Why?
Combined Modality Therapy1202185260.020 Why?
Survival Rate12021127100.020 Why?
Prognosis12021295880.010 Why?
Antineoplastic Combined Chemotherapy Protocols12021117350.010 Why?
Follow-Up Studies12021391080.010 Why?
Aged, 80 and over12021589460.010 Why?
Aged120211691790.000 Why?
Male120213606210.000 Why?
Female120213924850.000 Why?
Humans120217613260.000 Why?
Ojeaburu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (17)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.